How can Grover's disease (transient acantholytic dermatosis) be distinguished from primary hyperhidrosis, and what are the differences in their respective management strategies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating Grover's Disease from Hyperhidrosis

Grover's disease and primary hyperhidrosis are fundamentally different conditions that should not be confused: Grover's disease is an acantholytic dermatosis presenting with pruritic papulovesicular eruptions on the trunk, while hyperhidrosis is excessive sweating without primary skin lesions.

Clinical Differentiation

Grover's Disease (Transient Acantholytic Dermatosis)

Key diagnostic features:

  • Primary lesions: Itchy papules and vesicle-papules, typically 2-5mm in diameter 1
  • Distribution: Trunk (chest, back, abdomen), occasionally proximal extremities 1
  • Demographics: Middle-aged to elderly patients (mean age 59 years), male predominance (4:1 ratio) 1, 2
  • Appearance: Discrete erythematous papulovesicular eruptions, may have crusting
  • Symptoms: Intense pruritus is the hallmark symptom 1
  • Temporal pattern: Can be transient (weeks to months) or chronic; shows seasonal variation with increased incidence in winter 2

Primary Hyperhidrosis

Key diagnostic features:

  • Primary finding: Excessive sweating beyond thermoregulatory needs
  • No primary skin lesions: Skin appears normal except for moisture
  • Distribution: Typically palms, soles, axillae, face (focal hyperhidrosis) or generalized
  • Symptoms: Wetness, social embarrassment; pruritus is NOT a primary feature
  • Onset: Often begins in childhood or adolescence
  • Triggers: Emotional stress, heat, exercise

Diagnostic Confirmation

For Grover's Disease:

Skin biopsy is essential - shows focal acantholytic dyskeratosis with four possible histologic patterns (pemphigus vulgaris-like, Darier-like, Hailey-Hailey-like, or spongiotic) 1, 3. The pemphigus vulgaris pattern is most common 2.

For Hyperhidrosis:

  • Clinical diagnosis based on visible excessive sweating
  • Minor's starch-iodine test can quantify sweating areas
  • No histopathologic changes specific to primary hyperhidrosis

Important Clinical Pitfall

Grover's disease has been historically associated with heat and sweating 4, but recent evidence suggests it actually occurs MORE frequently in winter when skin is xerotic 2. This paradox is crucial: while excessive sweating was once thought causative, the disease likely relates to impaired epidermal integrity from xerosis and decreased sweat production 2. Therefore, the presence of hyperhidrosis does NOT indicate Grover's disease, and these conditions should not be conflated.

Management Differences

Grover's Disease Management

First-line therapy:

  • Topical corticosteroids (response rate 70%) - most frequently employed treatment 1
  • Apply moderate-to-high potency topical steroids (e.g., mometasone furoate 0.1% cream) to affected areas twice daily 5
  • Emollients to address underlying xerosis

Second-line therapy (for refractory cases):

  • Systemic retinoids (86% response rate) - acitretin or isotretinoin 1
  • Systemic corticosteroids (64% response rate) - prednisone for severe cases 1

Adjunctive measures:

  • Oral antihistamines for pruritus control
  • Avoid triggers: excessive heat, occlusive clothing, prolonged bed rest 4
  • Maintain skin hydration with emollients

Expected course: Spontaneous resolution occurs in 42% of cases within weeks to months 1

Hyperhidrosis Management

First-line therapy:

  • Topical aluminum chloride (20% solution) applied to dry skin at bedtime
  • Topical anticholinergics (glycopyrronium tosylate)

Second-line therapy:

  • Iontophoresis for palmar/plantar hyperhidrosis
  • Botulinum toxin injections for focal hyperhidrosis (axillary, palmar, plantar)

Third-line therapy:

  • Oral anticholinergics (oxybutynin, glycopyrrolate) for generalized hyperhidrosis
  • Microwave thermolysis or surgical sympathectomy for severe refractory cases

Key difference: Hyperhidrosis management focuses on reducing sweat production, while Grover's disease management targets inflammation and acantholysis.

Clinical Algorithm

  1. Patient presents with trunk eruption:

    • Are there visible papules/vesicles? → Consider Grover's disease
    • Is the primary complaint excessive sweating without lesions? → Consider hyperhidrosis
  2. If papulovesicular eruption present:

    • Perform skin biopsy to confirm acantholysis 1
    • Initiate topical corticosteroids
    • Address xerosis with emollients
  3. If excessive sweating without primary lesions:

    • Diagnose hyperhidrosis clinically
    • Initiate topical aluminum chloride
    • Consider escalation based on response

These are distinct entities requiring different diagnostic approaches and management strategies.

References

Research

Clinical features and treatments of transient acantholytic dermatosis (Grover's disease): a systematic review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020

Research

Seasonal variation of transient acantholytic dyskeratosis (Grover's disease).

Journal of the American Academy of Dermatology, 2006

Research

Grover disease (transient acantholytic dermatosis).

Archives of pathology & laboratory medicine, 2009

Research

Monolateral Grover's Disease with Blaschkoid Distribution.

Acta dermatovenerologica Croatica : ADC, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.